Hygieia, a digital therapeutics company, has relocated and expanded its headquarters to a new Livonia location to accommodate additional staff as it continues to grow and pursue partnerships with endocrinology practices across the U.S.
Hygieia’s expansion is in response to increased demand for access to its unique d-Nav Technology, which delivers autonomous insulin dose recommendations for people with type 2 diabetes.
“With two-thirds of those with type 2 diabetes failing to get their blood sugar under control, there is an immediate market need for Hygieia’s d-Nav Technology. Our program helps people get the precise dose of insulin they need at every injection, without weekly visits to the doctor,” says Doug Lawrence, who was appointed Hygieia CEO in August. “We provide a digital therapeutic that helps physicians manage their patients’ insulin therapy more efficiently. Our team is growing so we can seamlessly accommodate the increased demand.”
The company’s new headquarters in Livonia’s Laurel Office Park is 70 percent larger than its previous office. New staffing has grown by nearly 30 percent since late 2020 with roles being filled in operations, IT, sales, marketing, and clinical support with a focus on recruiting bilingual RNs and medical staff to continue serving its diverse population of patients.
Since January 2022, Hygieia has named company co-founder Dr. Israel Hodish medical director in addition to his role as research lead. Hodish oversees patient treatment plans and manages the clinical team.
It has entered clinical partnerships with Metro Detroit Endocrinology Center in Dearborn; Endocrine Associates of West Village, P.C., in Manhattan and Long Island City, N.Y.; and Physicians East in Greenville, N.C.
Alongside those moves, it has extended its international license in Northern Ireland, and added another in Israel, along with announcing the American Medical Association’s approval of two new Category III codes for autonomous insulin dose titration, which can be used for Hygieia’s d-Nav Technology.
For more information on Hygieia and the d-Nav insulin management technology, visit d-Nav.com or call 734-369-9980.
